{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:55:16Z","timestamp":1791086116910,"version":"4.1.0"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202530"],"award-info":[{"award-number":["82202530"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20230484295"],"award-info":[{"award-number":["20230484295"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.micpath.2026.108850","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:41:21Z","timestamp":1790350881000},"page":"108850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Host tyrosine kinase signaling and tyrosine kinase inhibitors as candidate host-directed therapies for tuberculosis"],"prefix":"10.1016","volume":"221","author":[{"given":"Xiaolin","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108850_bib1","series-title":"Global Tuberculosis Report 2025","author":"Organization","year":"2025"},{"key":"10.1016\/j.micpath.2026.108850_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/21505594.2018.1536598","article-title":"Autophagy: a new strategy for host-directed therapy of tuberculosis","volume":"10","author":"Paik","year":"2019","journal-title":"Virulence"},{"key":"10.1016\/j.micpath.2026.108850_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pharmthera.2019.05.008","article-title":"Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications","volume":"201","author":"Solouki","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2026.108850_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041831","article-title":"Receptor tyrosine kinase signaling and targeting in glioblastoma multiforme","volume":"22","author":"Tilak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108850_bib5","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1128\/MCB.01592-13","article-title":"Clinical targeting of mutated and wild-type protein tyrosine kinases in cancer","volume":"34","author":"Drake","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13045-020-00977-0","article-title":"Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020)","volume":"13","author":"Huang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.micpath.2026.108850_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106037","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2022 update","volume":"175","author":"Roskoski","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.micpath.2026.108850_bib8","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1021\/acs.jproteome.9b00895","article-title":"Relative and quantitative phosphoproteome analysis of macrophages in response to infection by virulent and avirulent mycobacteria reveals a distinct role of the cytosolic RNA sensor RIG-I in Mycobacterium tuberculosis pathogenesis","volume":"19","author":"Choudhary","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.micpath.2026.108850_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1074\/mcp.RA118.000929","article-title":"Macrophage phosphoproteome analysis reveals MINCLE-dependent and -independent mycobacterial cord factor signaling","volume":"18","author":"Hansen","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.micpath.2026.108850_bib10","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.jinf.2020.03.003","article-title":"Ibrutinib suppresses intracellular mycobacterium tuberculosis growth by inducing macrophage autophagy","volume":"80","author":"Hu","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.micpath.2026.108850_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41408-018-0136-x","article-title":"Effect of the BTK inhibitor ibrutinib on macrophage- and \u03b3\u03b4 T cell-mediated response against Mycobacterium tuberculosis","volume":"8","author":"Colado","year":"2018","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.micpath.2026.108850_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/acsinfecdis.7b00046","article-title":"The tyrosine kinase inhibitor Gefitinib restricts Mycobacterium tuberculosis growth through increased lysosomal biogenesis and modulation of cytokine signaling","volume":"3","author":"Sogi","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108850_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12943-018-0801-5","article-title":"Advances in studies of tyrosine kinase inhibitors and their acquired resistance","volume":"17","author":"Jiao","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.micpath.2026.108850_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jb\/mvz085","article-title":"Redox regulation of tyrosine kinase signalling: more than meets the eye","volume":"167","author":"Dustin","year":"2020","journal-title":"J. Biochem."},{"key":"10.1016\/j.micpath.2026.108850_bib15","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009043","article-title":"Complexity of receptor tyrosine kinase signal processing","volume":"5","author":"Volinsky","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ydbio.2017.10.017","article-title":"Feedback regulation of RTK signaling in development","volume":"447","author":"Neben","year":"2019","journal-title":"Dev. Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ceb.2020.01.016","article-title":"Receptor tyrosine kinase activation: from the ligand perspective","volume":"63","author":"Trenker","year":"2020","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib18","doi-asserted-by":"crossref","first-page":"11973","DOI":"10.1016\/S0021-9258(19)70229-4","article-title":"The purified product of the transforming gene of avian sarcoma virus phosphorylates tyrosine","volume":"255","author":"Levinson","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2026.108850_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(90)90801-K","article-title":"Signal transduction by receptors with tyrosine kinase activity","volume":"61","author":"Ullrich","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2026.108850_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101510","article-title":"Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer","volume":"36","author":"Rodr\u00edguez-Hern\u00e1ndez","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cells7030022","article-title":"Receptor tyrosine kinase ubiquitination and De-Ubiquitination in signal transduction and receptor trafficking","volume":"7","author":"Critchley","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.micpath.2026.108850_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.micpath.2026.108850_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.7716517","article-title":"Cytokine signaling through nonreceptor protein tyrosine kinases","volume":"268","author":"Taniguchi","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.micpath.2026.108850_bib135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-021-03959-5","article-title":"Structural basis of cytokine-mediated activation of ALK family receptors","volume":"600","author":"De Munck","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108850_bib136","first-page":"2726","article-title":"Function of Axl receptor tyrosine kinase in non-small cell lung cancer","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.micpath.2026.108850_bib137","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semcancer.2023.11.009","article-title":"Mutual regulation of TGF\u03b2-induced oncogenic EMT, cell cycle progression and the DDR","volume":"97","author":"Schuhwerk","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111031","article-title":"EPH receptor tyrosine kinases phosphorylate the PAR-3 scaffold protein to modulate downstream signaling networks","volume":"40","author":"Banerjee","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.micpath.2026.108850_bib139","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.29350","article-title":"Role of ErbB\/HER family of receptor tyrosine kinases in cholangiocyte biology","volume":"67","author":"Pellat","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.micpath.2026.108850_bib140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.critrevonc.2017.02.018","article-title":"FGFR a promising druggable target in cancer: molecular biology and new drugs","volume":"113","author":"Porta","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.micpath.2026.108850_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136978","article-title":"Revising endosomal trafficking under insulin receptor activation","volume":"22","author":"Iraburu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108850_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2018.12.023","article-title":"The LMTK-family of kinases: emerging important players in cell physiology and pathogenesis","volume":"1867","author":"Wendler","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.micpath.2026.108850_bib143","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3892\/or.2016.5297","article-title":"The met tyrosine kinase receptor as a therapeutic target and a potential cancer stem cell factor responsible for therapy resistance","volume":"37","author":"Miekus","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.micpath.2026.108850_bib144","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009167","article-title":"The role of MuSK in synapse formation and neuromuscular disease","volume":"5","author":"Burden","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ijbiomac.2022.01.113","article-title":"Targeting the PDGF\/PDGFR signaling pathway for cancer therapy: a review","volume":"202","author":"Zou","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2026.108850_bib146","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2183\/pjab.98.008","article-title":"RET receptor signaling: function in development, metabolic disease, and cancer","volume":"98","author":"Takahashi","year":"2022","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.micpath.2026.108850_bib147","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/bs.ctdb.2016.09.003","article-title":"ROR-family receptor tyrosine kinases","volume":"123","author":"Stricker","year":"2017","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib148","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202217367","article-title":"Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors","volume":"15","author":"Iyer","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.micpath.2026.108850_bib149","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009175","article-title":"The role of Ryk and Ror receptor tyrosine kinases in Wnt signal transduction","volume":"6","author":"Green","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib150","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3727\/096504016X14772424117423","article-title":"Knockdown of serine threonine tyrosine kinase 1 (STYK1) inhibits the migration and tumorigenesis in glioma cells","volume":"25","author":"Zhou","year":"2017","journal-title":"Oncol. Res."},{"key":"10.1016\/j.micpath.2026.108850_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061705","article-title":"Potential of tyrosine kinase receptor TIE-1 as novel therapeutic target in High-PI3K-Expressing ovarian cancer","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.micpath.2026.108850_bib152","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz383","article-title":"Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer","volume":"30","author":"Amatu","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.micpath.2026.108850_bib153","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib154","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/fcp.12097","article-title":"Pharmacology of Src family kinases and therapeutic implications of their modulators","volume":"29","author":"Kumar","year":"2015","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108850_bib155","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.phrs.2016.07.038","article-title":"Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases","volume":"111","author":"Roskoski","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.micpath.2026.108850_bib156","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/abbs\/gmv056","article-title":"A novel protein tyrosine kinase Tec identified in lamprey, Lampetra japonica","volume":"47","author":"Li","year":"2015","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.micpath.2026.108850_bib157","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/pro.4199","article-title":"Differences in the dynamics of the tandem-SH2 modules of the Syk and ZAP-70 tyrosine kinases","volume":"30","author":"Hobbs","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.micpath.2026.108850_bib158","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3892\/ol.2016.5481","article-title":"Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survival","volume":"13","author":"Mitsunari","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.micpath.2026.108850_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1148352","article-title":"Dissection of the catalytic and regulatory structure-function relationships of Csk protein tyrosine kinase","volume":"11","author":"Sun","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib160","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1128\/MCB.01454-13","article-title":"The capable ABL: what is its biological function?","volume":"34","author":"Wang","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib161","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10050139","article-title":"Proline-Rich protein tyrosine kinase 2 in inflammation and cancer","volume":"10","author":"Zhu","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.micpath.2026.108850_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cell.2007.05.055","article-title":"Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor","volume":"130","author":"Yuzawa","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2026.108850_bib25","article-title":"Relationships between DNA repair and RTK-mediated signaling pathways","volume":"1875","author":"Chabot","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.micpath.2026.108850_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-020-00361-x","article-title":"Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy","volume":"5","author":"Carter","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.micpath.2026.108850_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110525","article-title":"NF-\u03baB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity","volume":"130","author":"Xu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.micpath.2026.108850_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154773","article-title":"Probing the links: long non-coding RNAs and NF-\u03baB signalling in atherosclerosis","volume":"249","author":"Hussain","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.micpath.2026.108850_bib29","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.2174\/0109298673309489240816063313","article-title":"The investigation of Nf\u03bab inhibitors to block cell proliferation in OSCC cells lines","volume":"32","author":"Cheng","year":"2025","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108850_bib30","article-title":"Receptor tyrosine kinases and their signaling pathways as therapeutic targets of curcumin in cancer","volume":"12","author":"Sudhesh","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108850_bib31","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1039\/C5MB00101C","article-title":"The PI3K\/AKT\/mTOR interactive pathway","volume":"11","author":"Ersahin","year":"2015","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.micpath.2026.108850_bib32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00253-019-10257-8","article-title":"Targeting PI3K\/AKT\/mTOR-mediated autophagy for tumor therapy","volume":"104","author":"Xu","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108850_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.micpath.2026.108850_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.tips.2019.03.001","article-title":"Targeting SOCS proteins to control JAK-STAT signalling in disease","volume":"40","author":"Durham","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.micpath.2026.108850_bib35","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.3389\/fimmu.2018.02392","article-title":"Protein inhibitor of activated STAT (PIAS) negatively regulates the JAK\/STAT pathway by inhibiting STAT phosphorylation and translocation","volume":"9","author":"Niu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108850_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118642","article-title":"Rational design of dual PB2\/JAK2 inhibitors achieving balanced antiviral and host-directed immunomodulatory effects","volume":"307","author":"Yang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108850_bib37","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00018-008-7440-8","article-title":"The epidermal growth factor receptor family: biology driving targeted therapeutics","volume":"65","author":"Wieduwilt","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.micpath.2026.108850_bib38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tcb.2006.10.008","article-title":"ErbB receptors: new insights on mechanisms and biology","volume":"16","author":"Linggi","year":"2006","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib39","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s42003-023-04982-0","article-title":"An IL-17-EGFR-TRAF4 axis contributes to the alleviation of lung inflammation in severe influenza","volume":"6","author":"Dutta","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib40","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41467-024-44960-6","article-title":"EGFR core fucosylation, induced by hepatitis C virus, promotes TRIM40-mediated-RIG-I ubiquitination and suppresses interferon-I antiviral defenses","volume":"15","author":"Pan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108850_bib41","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1183\/09031936.00026910","article-title":"Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-\u03baB and EGFR pathways","volume":"36","author":"Hewson","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.micpath.2026.108850_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123656","article-title":"TRAF1 promotes the progression of Helicobacter pylori-associated gastric cancer through EGFR\/STAT\/OAS signalling","volume":"373","author":"Zhang","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.micpath.2026.108850_bib43","first-page":"5192","article-title":"Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor","volume":"14","author":"Batzer","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(92)90167-B","article-title":"The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling","volume":"70","author":"Lowenstein","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2026.108850_bib45","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/S0021-9258(17)41718-2","article-title":"Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation","volume":"269","author":"Hallberg","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2026.108850_bib46","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1101\/gad.12.23.3663","article-title":"c-Cbl\/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor","volume":"12","author":"Levkowitz","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.micpath.2026.108850_bib47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/15548627.2021.1936355","article-title":"Epigenetic reader BRD4 supports mycobacterial pathogenesis by co-modulating host lipophagy and angiogenesis","volume":"18","author":"Mukherjee","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.micpath.2026.108850_bib48","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2013.08.015","article-title":"EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance","volume":"154","author":"Wei","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2026.108850_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/auto.2.2.2458","article-title":"Autophagy signaling and the cogwheels of cancer","volume":"2","author":"Botti","year":"2006","journal-title":"Autophagy"},{"key":"10.1016\/j.micpath.2026.108850_bib50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4143\/crt.2018.084","article-title":"Impact of pulmonary tuberculosis on the EGFR mutational status and clinical outcome in patients with lung adenocarcinoma","volume":"51","author":"Hwang","year":"2019","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.micpath.2026.108850_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003946","article-title":"Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth","volume":"10","author":"Stanley","year":"2014","journal-title":"PLoS Pathog."},{"issue":"Suppl 1","key":"10.1016\/j.micpath.2026.108850_bib52","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1677\/erc.1.01280","article-title":"IGF1R signalling and its inhibition","volume":"13","author":"Riedemann","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.micpath.2026.108850_bib53","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41586-020-2369-7","article-title":"IGF1R is an entry receptor for respiratory syncytial virus","volume":"583","author":"Griffiths","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108850_bib54","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1021\/jacs.5c14196","article-title":"Living cell surfacome lysine footprinting (LiFT) captures virus-induced conformational dynamics and uncovers influenza A virus host factors","volume":"148","author":"Ma","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.micpath.2026.108850_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33393\/dti.2020.1548","article-title":"Identification of the possible therapeutic targets in the insulin-like growth factor 1 receptor pathway in a cohort of Egyptian hepatocellular carcinoma complicating chronic hepatitis C type 4","volume":"14","author":"Mabrouk","year":"2020","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.micpath.2026.108850_bib56","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.micpath.2026.108850_bib57","first-page":"1935","article-title":"Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin\/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling","volume":"5","author":"Pandini","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.micpath.2026.108850_bib58","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1038\/srep07735","article-title":"Insulin-like growth factor-1 endues monocytes with immune suppressive ability to inhibit inflammation in the intestine","volume":"5","author":"Ge","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108850_bib59","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.3748\/wjg.v23.i46.8109","article-title":"Relation of the IGF\/IGF1R system to autophagy in colitis and colorectal cancer","volume":"23","author":"Sipos","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.micpath.2026.108850_bib60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fendo.2015.00012","article-title":"Insulin\/Insulin-like growth factors in cancer: new roles for the aryl hydrocarbon receptor, tumor resistance mechanisms, and new blocking strategies","volume":"6","author":"Salisbury","year":"2015","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.micpath.2026.108850_bib61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2019.04.030","article-title":"IGF1R\/IRS1 targeting has cytotoxic activity and inhibits PI3K\/AKT\/mTOR and MAPK signaling in acute lymphoblastic leukemia cells","volume":"456","author":"Rodrigues Alves","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.micpath.2026.108850_bib62","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1021\/acsinfecdis.2c00278","article-title":"Human kinase IGF1R\/IR inhibitor linsitinib controls the in vitro and intracellular growth of Mycobacterium tuberculosis","volume":"8","author":"Wang","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108850_bib63","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","article-title":"VEGFs and receptors involved in angiogenesis versus lymphangiogenesis","volume":"21","author":"Lohela","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib64","doi-asserted-by":"crossref","first-page":"557","DOI":"10.5588\/ijtld.17.0609","article-title":"Tuberculous lymphadenitis is associated with altered levels of circulating angiogenic factors","volume":"22","author":"Kathamuthu","year":"2018","journal-title":"Int. J. Tubercul. Lung Dis."},{"key":"10.1016\/j.micpath.2026.108850_bib65","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajpath.2014.09.020","article-title":"Lymphangiogenesis is induced by mycobacterial granulomas via vascular endothelial growth factor receptor-3 and supports systemic T-cell responses against mycobacterial antigen","volume":"185","author":"Harding","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.micpath.2026.108850_bib66","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.celrep.2019.04.072","article-title":"VEGF-A from granuloma macrophages regulates granulomatous inflammation by a non-angiogenic pathway during mycobacterial infection","volume":"27","author":"Harding","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.micpath.2026.108850_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/srep33162","article-title":"Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination","volume":"6","author":"Polena","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108850_bib68","article-title":"Tuberculosis pathophysiology and anti-VEGF intervention","volume":"27","author":"Maison","year":"2022","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.micpath.2026.108850_bib69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(12)70321-3","article-title":"Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis","volume":"13","author":"Critchley","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108850_bib70","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/01.inf.0000131634.57368.45","article-title":"Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis","volume":"23","author":"van der Flier","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.micpath.2026.108850_bib71","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.micpath.2026.108850_bib72","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.micpath.2026.108850_bib73","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.4103\/ijo.IJO_1261_20","article-title":"Correlation of vascular endothelial growth factor with the clinical regression of tubercular granuloma","volume":"68","author":"Agarwal","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.micpath.2026.108850_bib74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40272-020-00433-z","article-title":"Ranibizumab: a review in retinopathy of prematurity","volume":"23","author":"Lee","year":"2021","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.micpath.2026.108850_bib75","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.4103\/ijo.IJO_508_20","article-title":"Management of optic disc granuloma in a patient of miliary tuberculosis with intravitreal ranibizumab in addition to antitubercular therapy","volume":"68","author":"Bansal","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.micpath.2026.108850_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107179","article-title":"The first-in-class pyrazole-based dual InhA-VEGFR inhibitors towards integrated antitubercular host-directed therapy","volume":"145","author":"Shaaban","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.micpath.2026.108850_bib77","article-title":"Granulomas microenvironment-guided sono-immunotherapy to treat and prevent recurrence of tuberculosis","volume":"17","author":"Wang","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108850_bib78","first-page":"29","article-title":"Dasatinib. Recent results","volume":"212","author":"Lindauer","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.micpath.2026.108850_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101804","article-title":"Protein tyrosine kinase Abl promotes hepatitis C virus particle assembly via interaction with viral substrate activator NS5A","volume":"298","author":"Miyamoto","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2026.108850_bib80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fimmu.2018.00085","article-title":"c-Abl-TWIST1 epigenetically dysregulate inflammatory responses during mycobacterial infection by Co-Regulating bone morphogenesis protein and miR27a","volume":"9","author":"Mahadik","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108850_bib81","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41374-021-00683-6","article-title":"c-Abl kinase regulates neutrophil extracellular trap formation and lung injury in abdominal sepsis","volume":"102","author":"Hawez","year":"2022","journal-title":"Lab. Invest."},{"key":"10.1016\/j.micpath.2026.108850_bib82","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.4049\/jimmunol.1201538","article-title":"Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophages","volume":"189","author":"Bruns","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2026.108850_bib83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-020-00364-w","article-title":"\u03b1-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment","volume":"15","author":"Karim","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.micpath.2026.108850_bib84","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3324\/haematol.2018.212027","article-title":"Phosphorylation of BECLIN-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia","volume":"105","author":"Yu","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.micpath.2026.108850_bib85","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2011.09.010","article-title":"Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis","volume":"10","author":"Napier","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2026.108850_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011387","article-title":"The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas","volume":"19","author":"Cleverley","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2026.108850_bib87","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1158\/1078-0432.CCR-04-1713","article-title":"Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-kappaB and Akt signaling pathways","volume":"11","author":"Appel","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.micpath.2026.108850_bib88","article-title":"Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection","author":"Zheng","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.micpath.2026.108850_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050506","article-title":"Nilotinib: a tyrosine kinase inhibitor mediates resistance to intracellular mycobacterium via regulating autophagy","volume":"8","author":"Hussain","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.micpath.2026.108850_bib90","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2009.09.028","article-title":"AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance","volume":"16","author":"O'Hare","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.micpath.2026.108850_bib91","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/eji.201847656","article-title":"The tyrosine kinase inhibitor dasatinib reduces the growth of intracellular Mycobacterium tuberculosis despite impairing T-cell function","volume":"48","author":"Wehrstedt","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2026.108850_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.654","article-title":"Drug-induced interstitial lung disease associated with dasatinib coinciding with active tuberculosis","volume":"8","author":"Tani","year":"2020","journal-title":"Respirol. Case Rep."},{"key":"10.1016\/j.micpath.2026.108850_bib93","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/1074-7613(95)90114-0","article-title":"Defective B cell development and function in Btk-deficient mice","volume":"3","author":"Khan","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2026.108850_bib94","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0968-0004(93)90192-P","article-title":"Regulation of src family tyrosine kinases in lymphocytes","volume":"18","author":"Mustelin","year":"1993","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.micpath.2026.108850_bib95","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1111\/jcmm.14548","article-title":"Effects of BTK signalling in pathogenic microorganism infections","volume":"23","author":"Ye","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.micpath.2026.108850_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abn8359","article-title":"The HIV-1 protein Nef activates the Tec family kinase Btk by stabilizing an intermolecular SH3-SH2 domain interaction","volume":"15","author":"Aryal","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.micpath.2026.108850_bib97","article-title":"BTK inhibitors for severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2): a systematic review","author":"Stack","year":"2021","journal-title":"Res Sq"},{"key":"10.1016\/j.micpath.2026.108850_bib98","doi-asserted-by":"crossref","first-page":"L52","DOI":"10.1152\/ajplung.00047.2018","article-title":"Inhibiting Bruton's tyrosine kinase rescues mice from lethal influenza-induced acute lung injury","volume":"315","author":"Florence","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.micpath.2026.108850_bib99","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1038\/ncomms8360","article-title":"Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury","volume":"6","author":"Ito","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108850_bib100","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa1509388","article-title":"Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia","volume":"373","author":"Burger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2026.108850_bib101","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1182\/blood-2013-06-507947","article-title":"Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes","volume":"122","author":"Dubovsky","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2026.108850_bib102","doi-asserted-by":"crossref","first-page":"65968","DOI":"10.18632\/oncotarget.11782","article-title":"Ibrutinib modifies the function of monocyte\/macrophage population in chronic lymphocytic leukemia","volume":"7","author":"Fiorcari","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.micpath.2026.108850_bib103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3324\/haematol.2014.107011","article-title":"Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy","volume":"100","author":"Da Roit","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.micpath.2026.108850_bib104","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bbrc.2004.09.171","article-title":"Src protein-tyrosine kinase structure and regulation","volume":"324","author":"Roskoski","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2026.108850_bib105","doi-asserted-by":"crossref","first-page":"15752","DOI":"10.18632\/oncotarget.4199","article-title":"Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells","volume":"6","author":"Poh","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.micpath.2026.108850_bib106","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2007-04-086017","article-title":"Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor","volume":"111","author":"Hiyoshi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2026.108850_bib107","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/acsinfecdis.1c00288","article-title":"Inhibitors of HIV-1 nef-mediated activation of the Myeloid Src-family kinase Hck block HIV-1 replication in macrophages and disrupt MHC-I downregulation","volume":"8","author":"Emert-Sedlak","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108850_bib108","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ebiom.2018.01.004","article-title":"HIV activates the tyrosine kinase hck to secrete ADAM protease-containing extracellular vesicles","volume":"28","author":"Lee","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.micpath.2026.108850_bib109","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/mi.2013.126","article-title":"Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)\/IL-6 axis","volume":"7","author":"Wang","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.micpath.2026.108850_bib110","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.1128\/MCB.21.23.8068-8081.2001","article-title":"Signaling through a novel domain of gp130 mediates cell proliferation and activation of Hck and Erk kinases","volume":"21","author":"Schaeffer","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.micpath.2026.108850_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.581011","article-title":"Hematopoietic cell kinase (HCK) is essential for NLRP3 inflammasome activation and lipopolysaccharide-induced inflammatory response in vivo","volume":"11","author":"Kong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108850_bib112","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1128\/IAI.68.8.4827-4830.2000","article-title":"Lipoarabinomannans activate the protein tyrosine kinase Hck in human neutrophils","volume":"68","author":"Astarie-Dequeker","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108850_bib113","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.4049\/jimmunol.161.9.4983","article-title":"Fusion of azurophil granules with phagosomes and activation of the tyrosine kinase Hck are specifically inhibited during phagocytosis of mycobacteria by human neutrophils","volume":"161","author":"N'Diaye","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2026.108850_bib114","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tube.2016.07.014","article-title":"New Mycobacterium tuberculosis LAM sublineage with geographical specificity for the old world revealed by phylogenetical and Bayesian analyses","volume":"101","author":"Reynaud","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2026.108850_bib115","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1462-5822.2008.01126.x","article-title":"The Delta fbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells","volume":"10","author":"Katti","year":"2008","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.micpath.2026.108850_bib116","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1182\/blood-2016-01-695098","article-title":"HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib","volume":"127","author":"Yang","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2026.108850_bib117","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2026.108850_bib118","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1038\/sj.onc.1206008","article-title":"Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis","volume":"21","author":"Wilson","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.micpath.2026.108850_bib119","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/MPA.0000000000000103","article-title":"The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion","volume":"43","author":"Je","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.micpath.2026.108850_bib120","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1158\/0008-5472.CAN-04-0504","article-title":"SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.micpath.2026.108850_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225887","article-title":"Expression of myeloid Src-family kinases is associated with poor prognosis in AML and influences Flt3-ITD kinase inhibitor acquired resistance","volume":"14","author":"Patel","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108850_bib122","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1158\/1535-7163.MCT-06-0446","article-title":"Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells","volume":"6","author":"Nam","year":"2007","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.micpath.2026.108850_bib123","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbadis.2016.11.013","article-title":"Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin\/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin\/PI3K pathway","volume":"1863","author":"Roversi","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.micpath.2026.108850_bib124","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00262-021-03111-2","article-title":"Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia","volume":"71","author":"Roversi","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.micpath.2026.108850_bib125","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220484","article-title":"Inherited human ITK deficiency impairs IFN-\u03b3 immunity and underlies tuberculosis","volume":"220","author":"Ogishi","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.micpath.2026.108850_bib126","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/imm.70003","article-title":"A novel small molecule ITK inhibitor suppresses Th2\/Th17 differentiation and attenuates airway inflammation in a mouse model of HDM-induced asthma","volume":"176","author":"Guo","year":"2025","journal-title":"Immunology"},{"key":"10.1016\/j.micpath.2026.108850_bib127","article-title":"Associations of genetic variants within TYK2 with pulmonary tuberculosis among Chinese population","volume":"12","author":"Zhang","year":"2024","journal-title":"Mol. Genet. Genom. Med."},{"key":"10.1016\/j.micpath.2026.108850_bib128","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1073\/pnas.1903561116","article-title":"Homozygosity for TYK2 P1104A underlies tuberculosis in about 1% of patients in a cohort of European ancestry","volume":"116","author":"Kerner","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2026.108850_bib129","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220094","article-title":"Impaired IL-23-dependent induction of IFN-\u03b3 underlies mycobacterial disease in patients with inherited TYK2 deficiency","volume":"219","author":"Ogishi","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.micpath.2026.108850_bib130","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau8714","article-title":"Tuberculosis and impaired IL-23-dependent IFN-\u03b3 immunity in humans homozygous for a common TYK2 missense variant","volume":"3","author":"Boisson-Dupuis","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.micpath.2026.108850_bib131","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.0105-2896.2004.00211.x","article-title":"Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4","volume":"202","author":"Watford","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.micpath.2026.108850_bib132","article-title":"The role of Syk\/CARD9-coupled C-type lectin receptors in immunity to Mycobacterium tuberculosis infections","volume":"2010","author":"Marakalala","year":"2010","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.micpath.2026.108850_bib133","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00043-15","article-title":"Targeting drug-sensitive and -Resistant strains of Mycobacterium tuberculosis by inhibition of src family kinases lowers disease burden and pathology","volume":"1","author":"Chandra","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.micpath.2026.108850_bib134","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.imlet.2019.07.008","article-title":"Positive association between MIC gene polymorphism and tuberculosis in Chinese population","volume":"213","author":"Chen","year":"2019","journal-title":"Immunol. Lett."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:44:23Z","timestamp":1791085463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026005760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":161,"alternative-id":["S0882401026005760"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108850","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host tyrosine kinase signaling and tyrosine kinase inhibitors as candidate host-directed therapies for tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108850"}}